Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pre-Operative Abobotulinumtoxin-A for Forehead Flap Donor Site Scar Aesthetics
NCT07720726Phase 4Not yet recruiting
- Sponsor
- Vanderbilt University Medical Center
- Start
- Sep 2026
- Primary completion
- Jun 2029
- Countries
- 1
01
Overview
A Phase 4 trial of abobotulinumtoxinA in surgical scar, sponsored by Vanderbilt University Medical Center. Planned start Sep 2026; status: not yet recruiting.
02
Drugs
abobotulinumtoxinA
03
Conditions
surgical scar
Beyond the preview
Go deeper on NCT07720726.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07720726.